Prostate cancer Posts - Page 41 of 80 on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Late-stage prostate cancer: Prolonging survival with immediate hormone therapy

Posted by on Jul 25, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared immediate and delayed androgen deprivation therapy (ADT) for men with relapsed or non-curable prostate cancer. Authors reported improved survival and disease progression with immediate ADT. Some background ADT is a type of hormone therapy used to treat prostate cancer. It targets the production of male hormones...

Read More

Examining the benefits of combining hormone therapy and radiation therapy

Examining the benefits of combining hormone therapy and radiation therapy

Posted by on Jul 18, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the evidence for combining androgen deprivation therapy (ADT) with radiation therapy for the treatment of high-risk localized prostate cancer. Authors concluded that the combined therapy approach was associated with a survival advantage for intermediate- and high-risk patients.  Some background ADT is a type...

Read More

The effect of combined radiation and hormone therapy on long-term fatigue

Posted by on Jul 18, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effect of combined radiation and hormone therapy on long-term fatigue. Researchers reported severe fatigue during and up to 4 years after treatment. Men with increased cancer markers and symptoms were more likely to report higher fatigue levels. Some background Radiation therapy and hormone therapy are often...

Read More

Hyopfractioned or standard external beam radiation therapy – which is better?

Posted by on Jul 11, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for low-risk localized prostate cancer. Researchers reported no differences in disease progression or survival. However, an increase in side effects was observed with H-EBRT. Some background Radiation therapy is a common treatment for...

Read More

High-risk prostate cancer: Surgery also a good treatment option for older men

High-risk prostate cancer: Surgery also a good treatment option for older men

Posted by on Jul 11, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined outcomes of different treatment options among older men (aged 70 or older) with high-risk prostate cancer. Authors reported lower disease recurrence rates for prostate surgery compared to radiation and radiation with hormone therapy. Some background Prostate surgery and radiation therapy are both common treatment...

Read More

Side Effects of Chemotherapy for Cancer: Infographic

Side Effects of Chemotherapy for Cancer: Infographic

Posted by on Jul 9, 2016 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer |

Chemotherapy Side Effects Resources Cancer survivorship is impacted by side effects of treatment.  Survivorship health information abounds on Medivizor:  from the post on neuropathy to the new guidelines that have been created for physicians to care for the side effects for breast cancer survivors.   In addition,  the Medivizor Library provides a...

Read More

Cancer cells left behind: Even close surgical margins increase the risk of recurrence

Cancer cells left behind: Even close surgical margins increase the risk of recurrence

Posted by on Jul 9, 2016 in Prostate cancer | 0 comments

In a nutshell This study investigated the risk of disease recurrence after prostate surgery based on surgical margins. Authors reported an increased risk of disease recurrence among men with close surgical margins. Some background Removal of the prostate gland is a common treatment of localized (confined) prostate cancer. Prostate surgery is...

Read More